MRI scan study to predict disability changes in MS
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study uses MRI scans to predict how quickly disability may worsen in people with multiple sclerosis (MS). It may help doctors spot people at higher risk of progression earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your MS has been diagnosed for 25 years or less
- Your disability is not too advanced (permanent wheelchair use score of 7 or less)
- You have MS (not another progressive nervous system disease)
- You can safely have an MRI (tell them about implants, pacemakers, metal, or pregnancy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new 3D MRI scan technique to find small, focused spinal cord lesions earlier in people with multiple sclerosis or early MS signs. It may help doctors detect changes sooner, even if lesions are not clearly visible on the first scan.
This study uses very high-strength MRI scans (7T) to look for brain imaging patterns that may predict how Alzheimer’s disease will progress. It may help doctors spot which changes are linked to faster or slower decline.
This study uses detailed MRI scans to look at brain “white matter” and “gray matter” changes in people with multiple sclerosis (MS). It may help researchers better understand how MS affects the brain and relates to symptoms.
This trial uses brain MRI and eye imaging tests to study research markers in people with multiple sclerosis (MS) and related neurologic conditions. It may help researchers better understand these diseases and how they change over time.
This study uses advanced MRI scans to see how they can help doctors better understand multiple sclerosis (MS). It compares images from people with MS to those without MS to find differences that may improve diagnosis and treatment.
This study follows adults with relapsing-remitting multiple sclerosis using MRI scans and blood tests. It aims to understand how the disease behaves and what markers in blood and imaging may relate to changes over time.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.